Search

Patrick James Orme

Examiner (ID: 13431, Phone: (313)446-4911 , Office: P/1779 )

Most Active Art Unit
1779
Art Unit(s)
1779
Total Applications
542
Issued Applications
301
Pending Applications
62
Abandoned Applications
193

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4989344 [patent_doc_number] => 20070155685 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-05 [patent_title] => 'Pharmaceutical composition' [patent_app_type] => utility [patent_app_number] => 10/591048 [patent_app_country] => US [patent_app_date] => 2005-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 27643 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20070155685.pdf [firstpage_image] =>[orig_patent_app_number] => 10591048 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/591048
Pharmaceutical composition Feb 27, 2005 Abandoned
Array ( [id] => 6952237 [patent_doc_number] => 20050227331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'Conjoined polynucleotide catalysts' [patent_app_type] => utility [patent_app_number] => 11/054106 [patent_app_country] => US [patent_app_date] => 2005-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13017 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20050227331.pdf [firstpage_image] =>[orig_patent_app_number] => 11054106 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/054106
Conjoined polynucleotide catalysts Feb 8, 2005 Abandoned
Array ( [id] => 7233172 [patent_doc_number] => 20050256072 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Dual functional oligonucleotides for use in repressing mutant gene expression' [patent_app_type] => utility [patent_app_number] => 11/055035 [patent_app_country] => US [patent_app_date] => 2005-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 16646 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20050256072.pdf [firstpage_image] =>[orig_patent_app_number] => 11055035 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/055035
Dual functional oligonucleotides for use in repressing mutant gene expression Feb 8, 2005 Abandoned
Array ( [id] => 5225016 [patent_doc_number] => 20070254282 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'Catalytic Polynucleotide and Its Use for Determination of Analytes' [patent_app_type] => utility [patent_app_number] => 10/588153 [patent_app_country] => US [patent_app_date] => 2005-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10221 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20070254282.pdf [firstpage_image] =>[orig_patent_app_number] => 10588153 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/588153
Catalytic Polynucleotide and Its Use for Determination of Analytes Jan 26, 2005 Abandoned
Array ( [id] => 7172165 [patent_doc_number] => 20050203044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Small-mer compositions and methods of use' [patent_app_type] => utility [patent_app_number] => 11/043673 [patent_app_country] => US [patent_app_date] => 2005-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 22604 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20050203044.pdf [firstpage_image] =>[orig_patent_app_number] => 11043673 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/043673
Small-mer compositions and methods of use Jan 25, 2005 Abandoned
Array ( [id] => 5769095 [patent_doc_number] => 20060019912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Cell transfecting formulations of small interfering RNA related compositions and methods of making and use' [patent_app_type] => utility [patent_app_number] => 11/018888 [patent_app_country] => US [patent_app_date] => 2004-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14489 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20060019912.pdf [firstpage_image] =>[orig_patent_app_number] => 11018888 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/018888
Cell transfecting formulations of small interfering RNA related compositions and methods of making and use Dec 19, 2004 Abandoned
Array ( [id] => 6918082 [patent_doc_number] => 20050095643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'Method of generating conditionally expressed mutant cells using expressible antisense sequences' [patent_app_type] => utility [patent_app_number] => 11/017379 [patent_app_country] => US [patent_app_date] => 2004-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10877 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20050095643.pdf [firstpage_image] =>[orig_patent_app_number] => 11017379 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/017379
Method of generating conditionally expressed mutant cells using expressible antisense sequences Dec 19, 2004 Abandoned
Array ( [id] => 6997381 [patent_doc_number] => 20050137159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-23 [patent_title] => 'Methods compositions and articles of manufacture for modulating bone growth' [patent_app_type] => utility [patent_app_number] => 11/003939 [patent_app_country] => US [patent_app_date] => 2004-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 19010 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20050137159.pdf [firstpage_image] =>[orig_patent_app_number] => 11003939 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/003939
Methods compositions and articles of manufacture for modulating bone growth Dec 5, 2004 Issued
Array ( [id] => 6983267 [patent_doc_number] => 20050153337 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'iRNA conjugates' [patent_app_type] => utility [patent_app_number] => 11/004379 [patent_app_country] => US [patent_app_date] => 2004-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 81769 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20050153337.pdf [firstpage_image] =>[orig_patent_app_number] => 11004379 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/004379
iRNA conjugates Dec 2, 2004 Abandoned
Array ( [id] => 7020052 [patent_doc_number] => 20050222071 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Topical administration of at least one double-stranded RNA oligonucleotide (dsRNA)' [patent_app_type] => utility [patent_app_number] => 11/001085 [patent_app_country] => US [patent_app_date] => 2004-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10139 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222071.pdf [firstpage_image] =>[orig_patent_app_number] => 11001085 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/001085
Topical administration of at least one double-stranded RNA oligonucleotide (dsRNA) Dec 1, 2004 Abandoned
Array ( [id] => 6944394 [patent_doc_number] => 20050196443 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-08 [patent_title] => 'Pulsatile release compositions and methods for enhanced intestinal drug absorption' [patent_app_type] => utility [patent_app_number] => 11/000814 [patent_app_country] => US [patent_app_date] => 2004-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 20393 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20050196443.pdf [firstpage_image] =>[orig_patent_app_number] => 11000814 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/000814
Pulsatile release compositions and methods for enhanced intestinal oligonucleotide drug absorption Nov 30, 2004 Issued
Array ( [id] => 7111073 [patent_doc_number] => 20050208528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Enhancement of the stability of oligonucleotides comprising phosphorothioate linkages by addition of water-soluble antioxidants' [patent_app_type] => utility [patent_app_number] => 10/997221 [patent_app_country] => US [patent_app_date] => 2004-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17149 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20050208528.pdf [firstpage_image] =>[orig_patent_app_number] => 10997221 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/997221
Enhancement of the stability of oligonucleotides comprising phosphorothioate linkages by addition of water-soluble antioxidants Nov 23, 2004 Abandoned
Array ( [id] => 7233141 [patent_doc_number] => 20050256069 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'IRNA agents with biocleavable tethers' [patent_app_type] => utility [patent_app_number] => 10/985426 [patent_app_country] => US [patent_app_date] => 2004-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 63422 [patent_no_of_claims] => 101 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20050256069.pdf [firstpage_image] =>[orig_patent_app_number] => 10985426 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/985426
IRNA agents with biocleavable tethers Nov 8, 2004 Issued
Array ( [id] => 5807671 [patent_doc_number] => 20060094025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Methods for detection of microrna molecules' [patent_app_type] => utility [patent_app_number] => 10/979052 [patent_app_country] => US [patent_app_date] => 2004-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8438 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20060094025.pdf [firstpage_image] =>[orig_patent_app_number] => 10979052 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/979052
Methods for detection of microrna molecules Nov 1, 2004 Abandoned
Array ( [id] => 7110696 [patent_doc_number] => 20050208151 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Treatment of rheumatoid arthritis with FLIP antagonists' [patent_app_type] => utility [patent_app_number] => 10/980145 [patent_app_country] => US [patent_app_date] => 2004-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 16189 [patent_no_of_claims] => 99 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20050208151.pdf [firstpage_image] =>[orig_patent_app_number] => 10980145 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/980145
Treatment of rheumatoid arthritis with FLIP antagonists Oct 31, 2004 Abandoned
Array ( [id] => 236321 [patent_doc_number] => 07595302 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-29 [patent_title] => 'Nucleic acids useful for triggering tumor cell lethality' [patent_app_type] => utility [patent_app_number] => 10/576818 [patent_app_country] => US [patent_app_date] => 2004-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 9627 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/595/07595302.pdf [firstpage_image] =>[orig_patent_app_number] => 10576818 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/576818
Nucleic acids useful for triggering tumor cell lethality Oct 24, 2004 Issued
Array ( [id] => 5667575 [patent_doc_number] => 20060172925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'Thio-siRNA aptamers' [patent_app_type] => utility [patent_app_number] => 10/968574 [patent_app_country] => US [patent_app_date] => 2004-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 19922 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20060172925.pdf [firstpage_image] =>[orig_patent_app_number] => 10968574 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/968574
Thio-siRNA aptamers Oct 18, 2004 Abandoned
Array ( [id] => 5656491 [patent_doc_number] => 20060142227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Amphiphylic peptide-PNA conjugates for the delivery of PNA through the blood brain barrier' [patent_app_type] => utility [patent_app_number] => 10/962669 [patent_app_country] => US [patent_app_date] => 2004-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7006 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20060142227.pdf [firstpage_image] =>[orig_patent_app_number] => 10962669 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/962669
Amphiphylic peptide-PNA conjugates for the delivery of PNA through the blood brain barrier Oct 12, 2004 Abandoned
Array ( [id] => 7005064 [patent_doc_number] => 20050170377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Regulation of bcl-2 gene expression' [patent_app_type] => utility [patent_app_number] => 10/961458 [patent_app_country] => US [patent_app_date] => 2004-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 14871 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20050170377.pdf [firstpage_image] =>[orig_patent_app_number] => 10961458 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/961458
Regulation of bcl-2 gene expression Oct 6, 2004 Issued
Array ( [id] => 5096160 [patent_doc_number] => 20070117769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-24 [patent_title] => 'Methods of modulating cell cycle and cell signaling pathways using biliverdin reductase' [patent_app_type] => utility [patent_app_number] => 10/584886 [patent_app_country] => US [patent_app_date] => 2004-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 41404 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20070117769.pdf [firstpage_image] =>[orig_patent_app_number] => 10584886 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/584886
Methods of modulating cell cycle and cell signaling pathways using biliverdin reductase Sep 28, 2004 Abandoned
Menu